RESEARCH TRIANGLE PARK, N.C., Feb. 15 /PRNewswire/ -- Max Neeman International, a leading Indian CRO, has formed an exclusive
Having already conducted multiple Minimally Invasive Device Trials for top device companies, the new specialized team adds another level of Company expertise for conducting Minimally Invasive Surgical Studies across multiple therapeutic areas. Patient numbers have been as high as 300 with major focus on peripheral vascular disease, gastric surgery and laparoscopy.
Max Neeman International's partner, Max Healthcare has over 800 beds and 12 hospitals throughout the country and is one of the leading hospital chains in India with an outstanding reputation and track record for quality health care.
About Max Healthcare
With over 800 beds, 12 hospitals, 1500 physicians and 3000 support staff - Max Healthcare is one of a leading chain of hospitals in India. Its state of the art infrastructure, over 225 ICU beds and most advanced technologies makes it one of the best hospitals in India. http://www.maxhealthcare.in
About Max Neeman International
Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2000 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 5 regional offices.
SOURCE Max Neeman International
Subscribe to our Free Newsletters!
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...View All